Stockreport

ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial [Yahoo! Finance]

ADC Therapeutics SA Common Shares  (ADCT) 
PDF LAUSANNE, Switzerland Dec. 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugate [Read more]